milken asia summit jean hynes thought leadership power of ideas

The power of capital to drive change

Jean Hynes, CFA, Chief Executive Officer
2023-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed.

Asset managers can help drive progress by conducting deep research to support the projects with the best prospects of fueling impactful results.

Jean Hynes, CFA
Chief Executive Officer

The world faces a host of daunting challenges, from the lingering pandemic to the effects of climate change. And yet, I can’t help but remain optimistic about the potential for science and innovation to solve some of our most pressing issues. After all, over three decades of investing in health care, I’ve seen firsthand the power that new ideas, backed by research and capital, have to cure diseases, produce lifesaving vaccines, and improve patient outcomes. 

The same spirit of progress is solving problems on a global scale. In my view, we are in the early days of an age of innovation driving real-world solutions, tangible progress, and long-term growth.

Let’s start with the industry I know best. My colleagues and I are as excited as ever about the countless disruptive technologies poised to reshape health care. Today, scientists are tackling disease-causing biology at unprecedented rates and with novel modalities. Decades of research have led us to what I believe is one of the most promising moments in the history of health care, where ideas that once seemed like science fiction are quickly becoming a reality.

In cancer, antibody drug conjugates now allow oncologists to attach a chemotherapy to an antibody and deliver treatment in a more targeted, efficacious, and tolerable way. Likewise, targeted protein degradation can hijack the body’s “garbage disposals” to eliminate proteins that cause specific diseases. This enables treatments that go after targets that were not previously addressable by traditional means. 

In my view, as we approach this new frontier in health care, it is easy to be hopeful. The near future will see the potential for technologies like RNA interference and gene therapy to cure numerous rare and serious diseases. In the wake of the pandemic, mRNA vaccines and related technology could combat viruses far beyond COVID, such as RSV and the flu. Finally, artificial intelligence and machine learning are poised to help researchers rapidly identify new treatment targets and drugs at a speed that outpaces traditional drug discovery methods. 

At the same time, I believe one of the world’s biggest challenges — climate change — will increasingly be tackled by innovative technological solutions. At Wellington Management, climate risk is an integral part of our research. Through our partnerships with the Woodwell Climate Research Center and MIT, we are constantly integrating physical and transition risks into our analysis. Combining the scientific insights of these organizations with our in-depth industry research, we’re putting capital behind climate technology innovations that could help the world mitigate and adapt to the problems posed by a changing climate. 

The next generation of community solar and integrated circuit panels offers new hardware solutions to the energy crisis. Groundbreaking alternative meat substitutes will make the food we eat more sustainable while AI-powered recycling will help to limit waste around the globe. These are just a few of the technological developments that will be brought to bear in the battle against climate change and the pursuit of a more sustainable future. 

Health care and climate change are just two of innumerable areas where the private sector is powering much-needed progress. I believe asset managers and asset owners have a key role to play in this progress by providing capital to disruptive companies across public and private markets. 

There are countless innovators attempting to solve the world’s problems and limited capital to fund these projects. Asset managers can positively influence these efforts by conducting deep research to support the projects with the best prospects of fueling impactful results. 

It is crucial to confront the world’s greatest challenges with a realistic understanding of the tasks in front of us. But I also believe we must remain optimistic about the potential for big ideas to tackle these issues head on. Though the problems we face are understandably top of mind, it’s important to remember the innovative thinkers working tirelessly in the background. In my view, as we enter the age of innovation, human ingenuity is more than capable of overcoming the challenges ahead.

Expert

Related insights

Showing of Insights Posts
Archived info
Consumer tech: Buy the dip or bide your time? Continue reading
event
Quick Take
2022-08-31
Archived info
Archived info
Tech WELLcovered: Legacy redefined Continue reading
event
Article
2022-11-30
Archived info
Archived info
Tech WELLcovered: Legacy redefined Continue reading
event
Article
2022-11-30
Archived info
Archived info
Tech WELLcovered: Life stages fulfilled Continue reading
event
Article
2022-10-31
Archived info
Archived info
Tech WELLcovered: experience transformed Continue reading
event
Article
2022-10-31
Archived info

Read next

DISCLOSURES

Past results are not necessarily indicative of future results and an investment can lose value. Funds returns are shown net of fees.
Source: Wellington Management

© 2022 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. The Overall Morningstar Rating for a fund is derived from a weighted average of the three, five, and ten year (if applicable) ratings, based on risk-adjusted return. Past performance is no guarantee of future results.

The content within this page is issued by Wellington Management Singapore Pte Ltd (UEN: 201415544E) (WMS). This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. Information contained on this website is provided for information purposes and does not constitute financial advice or recommendation in any security including but not limited to, share in the funds and is prepared without regard to the specific objectives, financial situation or needs of any particular person.

Investment in the funds described on this website carries a substantial degree of risk and places an investor’s capital at risk.  The price and value of investments is not guaranteed and may fall or rise. An investor may not get back the original amount invested and an investor may lose all of their investment. Investment in the funds described on this website is not suitable for all investors. Investors should read the prospectus and the Product Highlights Sheet of the respective fund and seek financial advice before deciding whether to purchase shares in any fund. Past performance or any economic trends or forecast, are not necessarily indicative of future performance. Some of the funds described on this website may use or invest in financial derivative instruments for portfolio management and hedging purposes. Investments in the funds are subject to investment risks, including the possible loss of the principal amount invested. None of the funds listed on this website guarantees distributions and distributions may fluctuate and may be paid out of capital. Past distributions are not necessarily indicative of future trends, which may be lower. Please note that payment of distributions out of capital effectively amounts to a return or withdrawal of the principal amount invested or of net capital gains attributable to that principal amount. Actual distribution of income, net capital gains and/or capital will be at the manager’s absolute discretion. Payments on dividends may result in a reduction of NAV per share of the funds. The preceding paragraph is only applicable if the fund intends to pay dividends/ distributions.  Performance with preliminary charge (sales charge) is calculated on a NAV to NAV basis, net of 5% preliminary charge (initial sales charge). Unless stated otherwise data is as at previous month end.

Subscriptions may only be made on the basis of the latest prospectus and Product Highlights Sheet, and they can be obtained from WMS or fund distributors upon request.

This material may not be reproduced or distributed, in whole or in part, without the express written consent of Wellington Management.